EGFR and lung carcinoma: Next, we investigated whether 8PN can reduce cell proliferation of lung cancer cells with different EGFR mutation status, including TC1 cells (EGFR wild‐type), Bm7 cells (EGFR wild‐type), and H1650 cells (EGFR exon 19 deletion and PTEN mutant).